First Tracks Biotherapeutics, Inc. (TRAX) stock
Close on Nov 17, 2026Market cap $1.56BP/E –Yield –
Earnings
First Tracks Biotherapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of First Tracks Biotherapeutics's earnings releases, newest first
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
First Tracks Biotherapeutics has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When First Tracks Biotherapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases First Tracks Biotherapeutics filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Update
- Update
- Results
- Results
- News
- Update
See a number that looks wrong?